Presentation Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease Presenter: John Eikelboom August 27, 2017 REGISTER for free or LOG IN to view this content Clinical Cardiology Clinical Pharma Prevention Coronary ACS/AMI CAD Pharma Presentation ESC 2017 Up Next Presentation Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial Presenter: Robert Giugliano August 28, 2017 More slides + Presentation DETermination of the role of OXygen in suspected Acute Myocardial Infarction Presenter: Robin Hofmann August 28, 2017 Presentation Guidelines for the Management of Acute Myocardial Infarction in Patients presenting with ST-Segment Elevation Presenter: Borja Ibanez August 28, 2017 We Recommend
Presentation Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial Presenter: Robert Giugliano August 28, 2017
Presentation DETermination of the role of OXygen in suspected Acute Myocardial Infarction Presenter: Robin Hofmann August 28, 2017
Presentation Guidelines for the Management of Acute Myocardial Infarction in Patients presenting with ST-Segment Elevation Presenter: Borja Ibanez August 28, 2017